PubMed:32178765 / 2740-2907
Annnotations
Inflammaging
{"project":"Inflammaging","denotations":[{"id":"T18","span":{"begin":0,"end":167},"obj":"Sentence"},{"id":"T18","span":{"begin":0,"end":167},"obj":"Sentence"}],"text":"Up to week 24, one patient in the placebo group died from cardiac failure and two had serious infections; no guselkumab-treated patient died or had serious infections."}
yaoziqian_800_3
{"project":"yaoziqian_800_3","denotations":[{"id":"T20","span":{"begin":34,"end":41},"obj":"CI"},{"id":"T21","span":{"begin":109,"end":119},"obj":"CI"}],"text":"Up to week 24, one patient in the placebo group died from cardiac failure and two had serious infections; no guselkumab-treated patient died or had serious infections."}
Zierdiyeerkenaili_800_3
{"project":"Zierdiyeerkenaili_800_3","denotations":[{"id":"T17","span":{"begin":109,"end":119},"obj":"CI"},{"id":"T25","span":{"begin":34,"end":41},"obj":"CI"}],"text":"Up to week 24, one patient in the placebo group died from cardiac failure and two had serious infections; no guselkumab-treated patient died or had serious infections."}